Nan Fung Life Sciences
VC
INVESTOR TYPE
Active
STATUS
25
PROFESSIONALS
45
INVESTMENTS
32
PORTFOLIO
11
EXITS
Description
Nan Fung Life Sciences, part of Nan Fung Group, is a global investment platform focusing on life sciences. Leveraging on Nan Fung Group's capital base and long-term commitment to the area, the company aims to become a partner for scientists, entrepreneurs, corporations and investors in the life science space. Through direct investments via Pivotal bioVenture Partners funds (both in US and China) and fund investments covering full spectrum of the industry (including therapeutics, medical devices and diagnostics) and across different development stages, Nan Fung Life Sciences has presence in both US and Greater China. The firm was founded in 2017 and is based in Hong Kong.
Website
Investor Status
Actively Seeking New Investments
Year Founded
2017
Primary Investor Type
Venture Capital
Other Investor Types
Accelerator/Incubator
PE/Buyout
Primary Office
- 23rd Floor, Nan Fung Tower
- 88 Connaught Road C, Central
- Hong Kong
- Hong Kong
Nan Fung Life Sciences Investments & Acquisitions (45)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Oncologie | 10-Jun-2019 | Early Stage VC | 0000 | Biotechnology | Clinical Trials - Phase 2 | |
| 0000000 000000 | 10-Apr-2019 | 00000 00000 | 0000 | Biotechnology | Startup | |
| 000000 00000000000 | 01-Apr-2019 | 00000 00000 | 0000 | Drug Discovery | Clinical Trials - Phase 2 | 0000000 0000000 00 |
| 000000 00000000000 | 25-Mar-2019 | 00000 00000 | 00000 | Drug Discovery | Clinical Trials - Phase 1 | 0000000 0000000 00 |
| 000000 00000000000 | 18-Feb-2019 | 00000 00000 | 00000 | Biotechnology | Startup | |
| 0000 0000000000000 | 05-Feb-2019 | 00000 00000 | 0000 | Biotechnology | Startup | 000000 000000 00.0 |
| 00000 | 19-Dec-2018 | 00000 00000 | 000.00 | Other Devices and Supplies | Generating Revenue | |
| 00000000 | 07-Nov-2018 | 00000 00000 | Other Consumer Products and Services | Startup | ||
| Galera Therapeutics | 30-Aug-2018 | Later Stage VC | 00000 | Biotechnology | Clinical Trials - Phase 3 | |
| Encodia | 20-Jul-2018 | Early Stage VC | 000 | Biotechnology | Generating Revenue |
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Nan Fung Life Sciences’s full profile, request a free trial.
Nan Fung Life Sciences Exits (10)
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Stealth BioTherapeutics | 15-Feb-2019 | IPO | 0000 | Completed |
|
| 00000000 000 | 08-Feb-2019 | 000 | 00000 | Completed |
|
| 00000 0000000000 | 31-Oct-2018 | 000 | 0000 | Completed |
|
| 0000000 0000000000 | 26-Sep-2018 | 000 | 0000 | Completed |
|
| 0000000 | 21-Jun-2018 | 000 | 00000 | Completed |
|
| 000000 00000000000 | 25-May-2018 | 000 | 0000 | Completed |
|
| 0000 000000 | 08-May-2018 | 000 | 00000 | Completed |
|
| 00000 000000000000 | 03-May-2018 | 000 | 0000 | Completed |
|
| Synlogic | 28-Aug-2017 | Reverse Merger | Completed |
|
|
| Athenex | 14-Jun-2017 | IPO | 0000 | Completed |
|
Nan Fung Life Sciences Team (13)
1 Former Team Member
You’re viewing 5 of 13 team members. Get the full list »Nan Fung Life Sciences Co-Investors (174)
| Name | With | Exits | Lead Partner |
|---|---|---|---|
| ARCH Venture Partners | 5 | 0 | 0 |
| Novo Holdings | 0 | 0 | |
| Sofinnova Ventures | 0 | 0 | |
| Bay City Capital | 0 | 0 | |
| Frazier Healthcare Partners | 0 | 0 | 0 |